DOTAGA-FAP-2286-ALB

Produktübersicht

• Artikelname: DOTAGA-FAP-2286-ALB
• Artikelnummer: MCE-HY-173374
• Hersteller Artikelnummer: HY-173374
• Alternativnummer: MCE-HY-173374-10MG,MCE-HY-173374-50MG,MCE-HY-173374-5MG,MCE-HY-173374-25MG,MCE-HY-173374-1MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

DOTAGA-FAP-2286-ALB is a derivative of Rofapitide tetraxetan (HY-147057). DOTAGA-FAP-2286-ALB is a selective fibroblast activation protein (FAP) inhibitor with an IC50 value of 67.5 nM. DOTAGA-FAP-2286-ALB enhances tumor retention via albumin interaction, prolonging blood circulation and improving radiometal complex stability (e.g., with 111In and 225Ac). DOTAGA-FAP-2286-ALB is promising for research of radionuclide therapy (TRT) of FAP-positive solid tumors[1].

Produkteigenschaften

• Molekulargewicht: 2072.21
• Reinheit: 99.29
• Formel: C91H131IN16O25S3
• Target-Kategorie: Drug Derivative,FAP

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound